Sylwia Anna Stopka, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Mass, Electrospray Ionization | 9 | 2023 | 267 | 3.250 |
Why?
|
| Lasers | 4 | 2019 | 952 | 1.340 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2023 | 508 | 1.330 |
Why?
|
| Molecular Imaging | 3 | 2020 | 817 | 1.140 |
Why?
|
| Bradyrhizobium | 3 | 2020 | 16 | 0.810 |
Why?
|
| Metabolomics | 8 | 2023 | 1626 | 0.800 |
Why?
|
| Chlamydomonas reinhardtii | 2 | 2015 | 34 | 0.620 |
Why?
|
| Limit of Detection | 1 | 2019 | 280 | 0.610 |
Why?
|
| Laser Therapy | 2 | 2023 | 1089 | 0.600 |
Why?
|
| Plant Roots | 2 | 2019 | 117 | 0.600 |
Why?
|
| Fasting | 1 | 2022 | 1603 | 0.530 |
Why?
|
| Root Nodules, Plant | 3 | 2020 | 11 | 0.490 |
Why?
|
| Microalgae | 1 | 2014 | 19 | 0.490 |
Why?
|
| Glioma | 6 | 2023 | 3420 | 0.440 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 2368 | 0.420 |
Why?
|
| Dentate Gyrus | 2 | 2023 | 163 | 0.410 |
Why?
|
| Photons | 1 | 2016 | 581 | 0.400 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3526 | 0.390 |
Why?
|
| Light | 1 | 2014 | 1344 | 0.310 |
Why?
|
| Silicon | 2 | 2020 | 141 | 0.290 |
Why?
|
| Glioblastoma | 4 | 2022 | 3482 | 0.280 |
Why?
|
| Benzbromarone | 1 | 2024 | 7 | 0.240 |
Why?
|
| Metabolome | 3 | 2020 | 976 | 0.230 |
Why?
|
| Symbiosis | 4 | 2020 | 293 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 2 | 2022 | 1093 | 0.220 |
Why?
|
| Nanostructures | 2 | 2020 | 547 | 0.220 |
Why?
|
| Ceramides | 1 | 2024 | 200 | 0.210 |
Why?
|
| Brain Neoplasms | 5 | 2024 | 8984 | 0.200 |
Why?
|
| Unfolded Protein Response | 1 | 2024 | 233 | 0.200 |
Why?
|
| Equipment Design | 3 | 2019 | 3520 | 0.190 |
Why?
|
| beta-Cyclodextrins | 1 | 2021 | 67 | 0.190 |
Why?
|
| Nitrogen Fixation | 4 | 2023 | 63 | 0.180 |
Why?
|
| Glutarates | 1 | 2022 | 244 | 0.180 |
Why?
|
| Calibration | 1 | 2023 | 816 | 0.180 |
Why?
|
| Setaria Plant | 1 | 2019 | 2 | 0.180 |
Why?
|
| Herbaspirillum | 1 | 2019 | 8 | 0.180 |
Why?
|
| Reference Standards | 1 | 2023 | 1004 | 0.170 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2022 | 927 | 0.170 |
Why?
|
| Sirtuins | 1 | 2022 | 320 | 0.160 |
Why?
|
| Cerebellar Neoplasms | 1 | 2024 | 585 | 0.160 |
Why?
|
| Rhizobiaceae | 1 | 2018 | 1 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 389 | 0.160 |
Why?
|
| Medulloblastoma | 1 | 2024 | 677 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2024 | 1135 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 551 | 0.150 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 772 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2024 | 1858 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1522 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2015 | 392 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2021 | 949 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 941 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2016 | 747 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2022 | 3011 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2024 | 2702 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1663 | 0.100 |
Why?
|
| Glucose | 1 | 2023 | 4361 | 0.100 |
Why?
|
| Mice | 10 | 2024 | 81216 | 0.090 |
Why?
|
| Animals | 12 | 2024 | 167940 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2021 | 1938 | 0.080 |
Why?
|
| Neoplasms | 3 | 2022 | 22066 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4554 | 0.080 |
Why?
|
| Glycolysis | 2 | 2023 | 828 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 22025 | 0.080 |
Why?
|
| Liver | 1 | 2022 | 7512 | 0.070 |
Why?
|
| Phospholipases | 1 | 2024 | 76 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8945 | 0.060 |
Why?
|
| Neurons | 1 | 2023 | 9416 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 18968 | 0.060 |
Why?
|
| Isotopes | 1 | 2023 | 125 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2024 | 287 | 0.060 |
Why?
|
| Convection | 1 | 2022 | 30 | 0.050 |
Why?
|
| Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
| Topotecan | 1 | 2022 | 132 | 0.050 |
Why?
|
| Uridine | 1 | 2022 | 142 | 0.050 |
Why?
|
| Humans | 14 | 2024 | 760261 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2022 | 429 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2022 | 412 | 0.050 |
Why?
|
| 5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
| Potassium Isotopes | 1 | 2020 | 9 | 0.050 |
Why?
|
| Oxygen Isotopes | 1 | 2020 | 43 | 0.040 |
Why?
|
| Niacinamide | 1 | 2022 | 414 | 0.040 |
Why?
|
| Phthalazines | 1 | 2022 | 377 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 11341 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 400 | 0.040 |
Why?
|
| Amines | 1 | 2021 | 281 | 0.040 |
Why?
|
| Polyesters | 1 | 2021 | 372 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2024 | 769 | 0.040 |
Why?
|
| Nitrogen | 1 | 2020 | 350 | 0.040 |
Why?
|
| Rest | 1 | 2023 | 915 | 0.040 |
Why?
|
| NAD | 1 | 2022 | 610 | 0.040 |
Why?
|
| Mutation | 4 | 2023 | 29950 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 833 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 961 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 854 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1129 | 0.040 |
Why?
|
| Triazoles | 1 | 2022 | 904 | 0.030 |
Why?
|
| Carbon | 1 | 2020 | 669 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2024 | 1805 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 16905 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Serum | 1 | 2016 | 211 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 2192 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1347 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 2138 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3160 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2023 | 3683 | 0.030 |
Why?
|
| Histones | 1 | 2023 | 2583 | 0.030 |
Why?
|
| Intestines | 1 | 2022 | 1907 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3584 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2023 | 2869 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 2823 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 788 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 3726 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1447 | 0.020 |
Why?
|
| Amino Acids | 1 | 2016 | 1715 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3758 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1190 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2218 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3826 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 5793 | 0.020 |
Why?
|
| Macrophages | 1 | 2022 | 5745 | 0.020 |
Why?
|
| Child | 2 | 2024 | 79758 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16543 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9274 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12100 | 0.010 |
Why?
|
| Male | 3 | 2023 | 359413 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13629 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 64947 | 0.010 |
Why?
|
| Female | 1 | 2023 | 391011 | 0.000 |
Why?
|